Why the study?
Does pericardiectomy improve survival compared to pericardiocentesis or medical therapy alone in patients with cardiac tamponade from extracardiac malignancy?
Does pericardiectomy improve survival compared to pericardiocentesis or medical therapy alone in patients with cardiac tamponade from extracardiac malignancy?
Pericardiectomy may offer a survival advantage over pericardiocentesis alone in patients presenting with cardiac tamponade due to extracardiac malignancy.
Answers are grounded in this paper and cite their sources.
Pericardiectomy may be associated with longer survival in malignant tamponade; leaves open whether surgery should be preferred in prospective trials.
Three cases of adenocarcinoma of the lung manifesting as acute pericardial effusion with tamponade are presented and the medical literature concerning this unusual manifestation of extracardiac malignancy is reviewed. We have found 22 cases of carcinoma and 4 cases of sarcoma. Of the carcinomas, 14 of 19 (74%) with known primary are pulmonary and 13 of 18 (72%) with tissue diagnosis are adenocarcinomas. Daignosis was made by cytologic examination of pericardial fluid in 14 of 16 cases (87%) in which it was performed. The lymphatic drainage of the heart renders some anatomical explanations for the prevalence of carcinoma of the lung as the cause of cardiac tamponade and the discrepancy of finding tumor cells in the pericardial fluid but not in the pericardium. Patients treated with pericardiectomy with or without ancillary radio- or chemotherapy survived longer than those treated with periocardiocentesis or radio- or chemotherapy alone.
No takes yet. Share an insight, caveat, or question.
Fraser et al. (1980) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: